Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi Pasteur
Biotech
Moderna turns R&D engine to next potential threat: monkeypox
As cases of monkeypox continue to creep up worldwide, Moderna is turning its vaccine platform towards finding a jab to defend against the disease.
Max Bayer
May 23, 2022 5:14pm
Sanofi culls early infectious disease, blood disorder asset
Jul 29, 2021 7:20am
Sanofi commits $476M a year to mRNA vaccine center
Jun 29, 2021 8:20am
2nd time lucky as Sanofi-GSK pass phase 2 COVID shot test
May 17, 2021 1:30am
Sanofi, hit by COVID-19 vaccine setback, kick-starts mRNA trial
Mar 12, 2021 10:44am
Sanofi, Translate release animal data on COVID-19 mRNA vaccine
Oct 15, 2020 10:00am
